Notably, stimulation of glioma cells (e.g., C6 or U251) has been associated with increased expression of IL-8, MCP-1, and VEGF, suggesting that P2X7R directly influences glioma cell-driven immune signalling [23,50]. Here, CCL2 is linked to central nervous system cancer.